FDA PMA FDA Class 3 30-Day Notice Accepted 🇺🇸 United States

Stent, Coronary

PMA: P110004 · Supplement: S035 · Decision Apr 9, 2020
Classifications
1
FEI Numbers
28
Registration Numbers
28

Basic Information

Device Name
Stent, Coronary
Trade Name
NIRxcell CoCr Coronary Stent on RX System
PMA Number
P110004
Supplement Number
S035
Device Class
FDA Class 3
Product Code
MAF
Generic Name
STENT, CORONARY
Medical Specialty
Unknown
Advisory Committee
Cardiovascular
Decision
30-Day Notice Accepted
Decision Code
OK30
Decision Date
April 9, 2020
Date Received
March 12, 2020
Supplement Type
30-Day Notice
Supplement Reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Expedited Review
N

Advisory Committee Statement

Expand the use of automation for the hydrophilic coating line of the delivery catheter.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
MAF Stent, Coronary